PEDIATRICS Vol. 79 No. 1 January 1987, pp. 157-160
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FISHER, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FISHER, M. C.

Transfusion-Associated Acquired Immunodeficiency Syndrome—What Is the Risk?

MARGARET C. FISHER MD1

1 Department of Pediatrics, Temple University School of Medicine, St Christopher's Hospital for Children, Philadelphia, PA

Relatively few pediatricians will ever care for a child with the acquired immunodeficiency syndrome (AIDS); yet, all will be asked questions about this disease. Parents want to know the risk of their children acquiring AIDS. The fear and even panic surrounding AIDS continues to escalate. To educate our patients and control panic, we must understand the disease and the routes of transmission.

It is now clear that AIDS is one end of the spectrum of illness caused by the human immunodeficiency virus (HIV, formerly called HTLV-III/LAV). The virus is present in blood and body fluids. It is transmitted from person to person by sexual contact and by exchange of blood.




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
R. C. Rodriguez, G. R. Buchanan, and M. S. Clanton
Prophylactic Cryoprecipitate in Congenital Afibrinogenemia
Clinical Pediatrics, November 1, 1988; 27(11): 543 - 545.
[Abstract] [PDF]